Grifulvin V

Active Ingredient(s): Griseofulvin
FDA Approved: * May 30, 1972
Pharm Company: * JOHNSON AND JOHNSON
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Grifulvin V Overview

Griseofulvin is an antifungal medication used to treat a number of types of dermatophytoses (ringworm).[1] This includes fungal infections of the nails and scalp, as well as the skin when antifungal creams have not worked.[2] It is taken by mouth.[1] Common side effects include allergic reactions, nausea, diarrhea, headache, trouble sleeping, and feeling tired.[1] It is not recommended in people with liver failure or porphyria.&a...

Read more Grifulvin V Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Griseofulvin

Recent Grifulvin V Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Griseofulvin
  • Capsule: 125mg, 250mg
  • Suspension: 125mg/5ml, 125mg/5ml + 125mg + 125mg/5ml
  • Tablet: 125mg, 165mg, 250mg, 330mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Grifulvin V: (1 result)

Sorted by National Drug Code
  • 0062-0214 Grifulvin V 500 mg Oral Tablet by Ortho-mcneil Pharmaceuticals

Other drugs which contain Griseofulvin or a similar ingredient: (5 results)

Related Grifulvin V Topics:

grifulvin side affects
rash on arm this medication givven ## Do you mean Griseofulvin ?... 1 reply
grifulvin
rash...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 3 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA